LDOS vs MKSI

Leidos (LDOS) presents a complex profile with a Piotroski F-Score of 4/9, indicating stable but not strong financial health. While the company exhibits exceptional profitability with an ROE of 31.03% and a low P/E of 13.12, it is currently battling negative revenue growth (-3.60%) and a severe bearish technical trend (0/100). The significant gap between the Graham Number ($98.74) and the growth-based Intrinsic Value ($328.63) suggests the market is struggling to price the company's transition from revenue expansion to margin optimization. Despite consistent earnings beats, the combination of insider selling and negative top-line growth warrants a neutral stance.

MKSI exhibits a stable financial health profile with a Piotroski F-Score of 4/9, though it is currently trading at a massive premium to its Graham Number ($63.07) and Intrinsic Value ($128.91). While the company boasts an exceptional 25-quarter earnings beat streak and strong growth metrics, the valuation is stretched with a trailing P/E of 62.51. This fundamental strength is countered by bearish insider sentiment and a severely weak technical trend (10/100), suggesting the stock may be overextended despite analyst 'buy' ratings.